Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Antimicrobial Agents and Chemotherapy
|
July 28, 2010
Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations
Marc Weiner, Charles Peloquin, William Burman, et al.
Emerging Infectious Diseases
|
November 23, 2020
Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States
Connie A Haley, Patricia Macias, Supriya Jasuja, et al.
Research Square
|
April 2, 2024
Dynamic PET Reveals Compartmentalized Brain and Lung Tissue Antibiotic Exposures
Sanjay Jain, Xueyi Chen, Bhavatharini Arun, et al.
Journal of the Pediatric Infectious Diseases Society
|
March 15, 2020
Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment
Claire Szipszky, Daniel Van Aartsen, Sarah Criddle, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 25, 2019
Isoniazid and Rifapentine Treatment Eradicates Persistent <i>Mycobacterium tuberculosis</i> in Macaques
Taylor W Foreman, Allison N Bucşan, Smriti Mehra, et al.
BMC Infectious Diseases
|
August 29, 2016
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
Meredith Milstein, Leonid Lecca, Charles Peloquin, et al.
Antimicrobial Agents and Chemotherapy
|
April 24, 2019
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients
Simone H J van den Elsen, Marieke G G Sturkenboom, Onno W Akkerman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 3, 2024
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid
Jeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Plos One
|
March 3, 2025
Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid
Jeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Antimicrobial Agents and Chemotherapy
|
July 28, 2010
Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations
Marc Weiner, Charles Peloquin, William Burman, et al.
Emerging Infectious Diseases
|
November 23, 2020
Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States
Connie A Haley, Patricia Macias, Supriya Jasuja, et al.
Research Square
|
April 2, 2024
Dynamic PET Reveals Compartmentalized Brain and Lung Tissue Antibiotic Exposures
Sanjay Jain, Xueyi Chen, Bhavatharini Arun, et al.
Journal of the Pediatric Infectious Diseases Society
|
March 15, 2020
Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment
Claire Szipszky, Daniel Van Aartsen, Sarah Criddle, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 25, 2019
Isoniazid and Rifapentine Treatment Eradicates Persistent <i>Mycobacterium tuberculosis</i> in Macaques
Taylor W Foreman, Allison N Bucşan, Smriti Mehra, et al.
BMC Infectious Diseases
|
August 29, 2016
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
Meredith Milstein, Leonid Lecca, Charles Peloquin, et al.
Antimicrobial Agents and Chemotherapy
|
April 24, 2019
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients
Simone H J van den Elsen, Marieke G G Sturkenboom, Onno W Akkerman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 3, 2024
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid
Jeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Plos One
|
March 3, 2025
Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid
Jeffrey M Collins, Maia Kipiani, Yutong Jin, et al.
Page
of 3